Timothy R. Pearson

Mr. Pearson is currently Chief Executive Officer of Carrick Therapeutics, a privately-held biopharmaceutical company focusing on the innovative research and development of transformative oncology medicines. He previously served as Chief Financial Officer and Executive Vice President for TESARO, Inc., a publicly held oncology-focused biopharmaceutical company. Previous positions include EVP and CFO at Catalyst Health Solutions, a publicly held pharmacy benefit manager with over $5bn in revenues, and EVP and CFO at MedImmune, where he had functional responsibility for finance, information technology, strategic planning, and governance. Mr. Pearson previously served on the board of directors of Ra Pharmaceuticals, Inc., a publicly held biopharmaceutical company until its acquisition by UCB in 2020. He is a CPA, holds B.S. degrees in Business Administration from the University of Delaware and in Accounting from the University of Maryland University College, and an M.S. in Finance from Loyola University.